Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM)

by Lapointe, Réjean, Jamal, Rahima, van Kempen, Leon, Thebault, Pamela, Belanger, Karl, Friedmann, Jennifer, Ayoub, Jean-Pierre, Cocolakis, Eftihia, Kazemi, Shirin, Dionne, Jeanne, Lambert, Caroline, Le, Huy, Grange, Cecile, Cailhier, Jean-Francois, Spatz, Alan, Miller, Wilson
Published 2015